Tango Therapeutics CFO, R&D President, and Director Sell Shares on 2026-02-03

Tango Therapeutics, Inc. has announced that Chief Financial Officer Beckman Daniella has executed two transactions on February 3, 2026. Firstly, she sold 113 shares at a price of $12.9 per share. Secondly, she sold 10,204 shares at a price of $12.26 per share. Furthermore, President, R&D Crystal Adam also executed two transactions on the same day. Firstly, she sold 201 shares at a price of $12.9 per share. Secondly, she sold 18,251 shares at a price of $12.26 per share. Additionally, Director, Director, Executive Chair Weber Barbara executed two transactions on February 3, 2026. Firstly, she sold 33,186 shares at a price of $12.26 per share. Secondly, she sold 333 shares at a price of $12.9 per share.